Related Experiment Video
Updated: Nov 4, 2025

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
How do you mend inactive tumor suppressor mutants? You glue them!
1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94143, USA.
Abstract:
SMAD4 mutations that disrupt its interaction with SMAD3 and attenuate tumor suppression by TGF-β are major oncogenic drivers. Tang et al. (2020) report the discovery of small molecules that restore the SMAD4:SMAD3 complex and its cytostatic activity, exemplifying the therapeutic potential of fixing tumor suppressor mutants using molecular glues.
Insights
Researchers discovered small molecules that restore the SMAD4:SMAD3 complex, re-establishing tumor suppression. This finding highlights the potential of molecular glues to fix tumor suppressor mutations and treat cancer.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- SMAD4 mutations are key drivers of cancer by disrupting the tumor-suppressive TGF-β pathway.
- These mutations impair the interaction between SMAD4 and SMAD3, critical components of the TGF-β signaling cascade.
Purpose of the Study:
- To identify therapeutic strategies for restoring SMAD4 function in cancer.
- To explore the potential of small molecules in correcting SMAD4 mutations and reactivating tumor suppression.
Main Methods:
- Discovery of novel small molecules.
- Biochemical assays to assess the restoration of the SMAD4:SMAD3 complex.
- Evaluation of the cytostatic activity of the restored complex.
Main Results:
- Identification of small molecules capable of restoring the SMAD4:SMAD3 complex.
- Demonstration that these molecules re-establish the cytostatic function of the SMAD4:SMAD3 complex.
- Evidence of reactivated tumor suppression in the presence of these molecules.
Conclusions:
- Small molecules can effectively restore the function of mutated SMAD4.
- This approach, termed molecular glues, shows therapeutic promise for cancers driven by SMAD4 mutations.
- Fixing tumor suppressor mutants represents a viable strategy for cancer treatment.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
07:55A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
Published on: March 7, 2019
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In-vitro Mutagenesis
Targeted Cancer Therapies
There are several types of targeted therapies against...
DNA Damage can Stall the Cell Cycle